Beyond Air, Inc. (XAIR) shareholders
Close on Nov 18, 2026Market cap $1.77MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Marc Lasry Joint filing with Avenue Capital Management II, L.P. (8.86%), Avenue Venture Opportunities Fund II, L.P. (5.31%) and 2 more | 8,072,872 | 8.86% | 13G (passive) amendment | Dec 31, 2024 |
| Alyeska Fund GP, LLC Joint filing with Alyeska Investment Group, L.P. (9.90%), Anand Parekh (9.90%) | 7,146,576 | 9.90% | 13G (passive) | Dec 31, 2024 |
| Charles Mosseri Marlio | 3,330,250 | 9.21% | 13G (passive) amendment | Dec 31, 2023 |
| Balyasny Asset Management Holdings LP Joint filing with Balyasny Asset Management L.P. (9.27%), Bam Gp LLC (9.27%) and 2 more | 763,266 | 9.27% | 13G (passive) amendment | Sep 30, 2025 |
| Bam Gp LLC Joint filing with Balyasny Asset Management L.P. (5.30%), Balyasny Asset Management Holdings LP (5.30%) and 2 more | 763,266 | 5.30% | 13G (passive) amendment | Jun 30, 2026 |
| Dames GP LLC Joint filing with Balyasny Asset Management L.P. (7.25%), Bam Gp LLC (7.25%) and 2 more | 763,266 | 7.25% | 13G (passive) amendment | Mar 31, 2026 |
| Anand Parekh Joint filing with Alyeska Investment Group, L.P. (7.27%), Alyeska Fund GP, LLC (7.27%) | 582,638 | 7.27% | 13G (passive) amendment | Dec 31, 2025 |
| Lin Yi-Chien | 148,000 | 8.90% | 13G (passive) amendment | Oct 12, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of XAIR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Balyasny Asset Management L.P. | 23,208 | 2.42% | $206.97K | – | 0.00% |
| Murchinson Ltd. | 13,710 | 1.43% | $122.27K | −2,789 | 0.02% |
| Daytona Street Capital LLC | 7,578 | 0.79% | $61.45K | −265 | 0.04% |
| Geode Capital Management, LLC | 5,612 | 0.59% | $50.05K | −2,360 | 0.00% |
| Bleichroeder LP | 4,324 | 0.45% | $38.57K | – | 0.01% |
| Vanguard Capital Management LLC | 3,137 | 0.33% | $27.98K | +1,540 | 0.00% |
| Commonwealth Equity Services, LLC | 2,369 | 0.25% | $21.13K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 1,468 | 0.15% | $13.10K | – | 0.00% |
| BlackRock, Inc. | 1,102 | 0.12% | $9.83K | – | 0.00% |
| StoneX Group Inc. | 1,078 | 0.11% | $9.97K | New | 0.00% |
| Hrt Financial LP | 1,055 | 0.11% | $9.00K | New | 0.00% |
| XTX Topco Ltd | 884 | 0.09% | $7.88K | +281 | 0.00% |
| Northern Trust Corp | 852 | 0.09% | $7.60K | New | 0.00% |
| Wealth Effects LLC | 848 | 0.09% | $7.57K | −570 | 0.00% |
| Baldwin Brothers LLC/Ma | 740 | 0.08% | $6.60K | – | 0.00% |
| Osaic Holdings, Inc. | 406 | 0.04% | $3.65K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 229 | 0.02% | $2.04K | – | 0.00% |
| PFS Partners, LLC | 100 | 0.01% | $892 | – | 0.00% |
| IFP Advisors, Inc | 57 | 0.01% | $507 | – | 0.00% |
| NewEdge Advisors, LLC | 23 | 0.00% | $204 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 29 | 0M | 7.2% | 5 / 2 | 4 / 4 | 0M | 0M |
| Q1 2026 | 29 | 0M | 7.3% | 6 / 1 | 9 / 3 | 0M | 0M |
| Q4 2025 | 27 | 0M | 7.4% | 5 / 2 | 9 / 6 | 0M | 0M |
| Q3 2025 | 28 | 0M | 8.5% | 27 / 0 | 1 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Robert Scott Goodman | Chief Executive Officer, Director | 34,822 | 3.64% | Jul 31, 2026 |
| Steven A. Lisi | CEO and Chairman of the Board, Director | 3,327,411 | 347.46% | Nov 6, 2025 |
| Daniel J. Moorhead | Chief Financial Officer | 4,340 | 0.45% | Jul 31, 2026 |
| Michael A. Gaul | Chief Operating Officer | 94,150 | 9.83% | Nov 24, 2025 |
| Douglas Quinton Larson | Chief Financial Officer | 27,548 | 2.88% | Nov 6, 2025 |
| Yoori Lee | Director | 12,654 | 1.32% | Nov 24, 2025 |
| Robert Carey | Director | 5,553,490 | 579.92% | Nov 7, 2025 |
| Erick Lucera | Director | 43,608 | 4.55% | Nov 6, 2025 |
| William P. Forbes | Director | 14,855 | 1.55% | Nov 6, 2025 |
| Ron Bentsur | Director | 144,736 | 15.11% | Nov 26, 2024 |
| Yi-Chien Lin | 10% owner | 148,000 | 15.45% | Oct 14, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Yi-Chien Lin 10% owner | Oct 13, 2026 | Buy | +2,607 | $2.21 | $5.76K | 148,000 |
| Yi-Chien Lin 10% owner | Oct 1, 2026 | Buy | +15,393 | $2.80 | $43.10K | 145,393 |
| Yi-Chien Lin 10% owner | Sep 30, 2026 | Buy | +2,000 | $2.71 | $5.42K | 130,000 |
| Yi-Chien Lin 10% owner | Sep 29, 2026 | Buy | +3,000 | $2.69 | $8.07K | 128,000 |
| Daniel J. Moorhead Chief Financial Officer | Jul 29, 2026 | Buy | +4,340 | $5.76 | $25.00K | 4,340 |
| Robert Scott Goodman Chief Executive Officer, Director | Jul 29, 2026 | Buy | +34,722 | $5.76 | $200.00K | 34,822 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Jul 21, 2025 | Buy | +6,000 | $3.25 | $19.50K | 3,327,411 |
| Robert Carey Director | Mar 14, 2025 | Buy | +10,000 | $0.26 | $2.60K | 4,076,864 |
| Robert Carey Director | Mar 14, 2025 | Buy | +990,000 | $0.25 | $247.50K | 4,066,864 |
| Michael A. Gaul Chief Operating Officer | Feb 19, 2025 | Buy | +6,000 | $0.38 | $2.28K | 94,150 |
| Robert Carey Director | Sep 26, 2024 | Buy | +1,476,626 | $0.50 | $738.31K | 1,476,626 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Sep 26, 2024 | Buy | +1,476,626 | $0.50 | $738.31K | 3,249,411 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Aug 15, 2024 | Buy | +50,000 | $0.37 | $18.50K | 1,772,785 |
| Erick Lucera Director | Aug 14, 2024 | Buy | +39,266 | $0.40 | $15.71K | 43,608 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Aug 14, 2024 | Buy | +100,000 | $0.39 | $39.00K | 1,722,785 |
| Robert Carey Director | Aug 14, 2024 | Buy | +100,000 | $0.40 | $40.00K | 3,076,864 |
| Robert Carey Director | Mar 20, 2024 | Award | +602,410 | $1.66 | $1.00M | 2,976,864 |
| Douglas Quinton Larson Chief Financial Officer | Mar 20, 2024 | Award | +12,048 | $1.66 | $20.00K | 27,548 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Mar 20, 2024 | Award | +78,314 | $1.66 | $130.00K | 1,614,785 |
| Amir Avniel Chief Business Officer, Director | Dec 28, 2023 | Sale | −13,733 | $2.05 | $28.15K | 0 |
| Amir Avniel Chief Business Officer, Director | Dec 28, 2023 | Sale | −11,267 | $2.06 | $23.21K | 685,760 |
| Jeff Lynn Myers Chief Medical Officer | Dec 27, 2023 | Sale | −3,423 | $2.21 | $7.56K | 46,577 |
| Robert Carey Director | Dec 18, 2023 | Buy | +1,200,000 | $1.64 | $1.97M | 2,374,454 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Dec 18, 2023 | Buy | +77,775 | $1.63 | $126.77K | 1,536,471 |
| Michael A. Gaul Chief Operating Officer | Nov 16, 2023 | Buy | +10,000 | $1.77 | $17.70K | 88,150 |
| Robert Carey Director | Aug 28, 2023 | Buy | +250,000 | $2.70 | $675.00K | 1,225,160 |
| Robert Carey Director | Aug 21, 2023 | Buy | +75,050 | $2.76 | $207.14K | 975,160 |
| Robert Carey Director | Aug 18, 2023 | Buy | +13,614 | $2.64 | $35.94K | 900,110 |
| Michael A. Gaul Chief Operating Officer | Jun 30, 2023 | Buy | +5,000 | $4.51 | $22.55K | 78,150 |
| William P. Forbes Director | Mar 31, 2023 | Buy | +5,000 | $6.67 | $33.35K | 14,855 |
| Robert Carey Director | Mar 30, 2023 | Buy | +10,000 | $6.45 | $64.50K | 886,496 |
| Amir Avniel Chief Business Officer, Director | Mar 29, 2023 | Award | +240,000 | – | – | 697,027 |
| Robert Carey Director | Mar 29, 2023 | Buy | +10,000 | $6.30 | $63.00K | 876,496 |
| Yoori Lee Director | Mar 28, 2023 | Buy | +3,115 | $6.34 | $19.75K | 12,654 |
| Jeff Lynn Myers Chief Medical Officer | Mar 27, 2023 | Award | +50,000 | – | – | 50,000 |
| Michael A. Gaul Chief Operating Officer | Mar 24, 2023 | Buy | +1,000 | $6.15 | $6.15K | 73,150 |
| Ron Bentsur Director | Mar 20, 2023 | Buy | +2,300 | $6.48 | $14.90K | 144,736 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Mar 17, 2023 | Buy | +10,000 | $6.46 | $64.60K | 1,458,696 |
| William P. Forbes Director | Mar 17, 2023 | Buy | +5,000 | $6.46 | $32.30K | 9,855 |
| Robert Carey Director | Mar 16, 2023 | Gift | −28,656 | – | – | 835,840 |
| Erick Lucera Director | Mar 16, 2023 | Buy | +2,000 | $6.82 | $13.64K | 4,342 |
| Robert Carey Director | Mar 14, 2023 | Buy | +10,000 | $6.85 | $68.50K | 866,496 |
| Amir Avniel Chief Business Officer, Director | Mar 13, 2023 | Buy | +1,000 | $6.40 | $6.40K | 457,027 |
| Robert Carey Director | Mar 13, 2023 | Buy | +4,173 | $6.15 | $25.66K | 856,496 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Mar 8, 2023 | Buy | +5,000 | $5.89 | $29.45K | 1,447,849 |
| Robert Carey Director | Mar 8, 2023 | Buy | +10,000 | $5.95 | $59.50K | 852,323 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Mar 7, 2023 | Buy | +45,000 | $5.98 | $269.10K | 1,442,849 |
| Michael A. Gaul Chief Operating Officer | Mar 7, 2023 | Buy | +8,000 | $5.86 | $46.88K | 72,150 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Feb 16, 2023 | Sale | −48,596 | $6.10 | $296.44K | 1,397,849 |
| Robert Carey Director | Dec 7, 2022 | Buy | +20,000 | $5.75 | $115.00K | 842,323 |
| Robert Carey Director | Dec 2, 2022 | Gift | −16,000 | – | – | 864,496 |
| Robert Carey Director | Nov 29, 2022 | Buy | +15,000 | $5.75 | $86.25K | 822,323 |
| Robert Carey Director | Nov 28, 2022 | Buy | +15,000 | $5.75 | $86.25K | 807,323 |
| Robert Carey Director | Nov 18, 2022 | Buy | +20,000 | $5.80 | $116.00K | 792,323 |
| Robert Carey Director | Nov 17, 2022 | Buy | +20,000 | $5.90 | $118.00K | 772,323 |
| Robert Carey Director | Nov 16, 2022 | Buy | +10,000 | $6.00 | $60.00K | 752,323 |
| Michael A. Gaul Chief Operating Officer | Aug 22, 2022 | Buy | +2,000 | $9.42 | $18.84K | 64,150 |
| Amir Avniel COO and President, Director | Jun 30, 2022 | Sale | −2,600 | $6.57 | $17.08K | 13,733 |
| Amir Avniel COO and President, Director | Jun 30, 2022 | Sale | −65,500 | $6.50 | $425.75K | 408,027 |
| Robert Carey Director | Jun 30, 2022 | Buy | +175,000 | $6.45 | $1.13M | 742,323 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Beyond Air's stock actually held short. Settlement fails (shares not delivered on time) peaked at 62,277 shares on Sep 1, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Amir Avniel Officer | Aug 22, 2024 | 180,415 | $83.44K | Aug 22, 2024 | Private placement |
| Amir Avniel Director | Dec 29, 2023 | 50,000 | $108.50K | Dec 28, 2023 | Private Placement |
See a number that looks wrong?